A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Public ClinicalTrials.gov record NCT07359846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma
Study identification
- NCT ID
- NCT07359846
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Generate Biomedicines
- Industry
- Enrollment
- 786 participants
Conditions and interventions
Conditions
Interventions
- GB-0895 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
- Last update posted
- Apr 12, 2026
2026 – 2029
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site 10 | West Covina | California | 91790 | Recruiting |
| Research Site 06 | Miami | Florida | 33126 | Recruiting |
| Research Site 03 | Miami | Florida | 33135 | Recruiting |
| Research 09 | Orlando | Florida | 32807 | Recruiting |
| Research Site 01 | Tamarac | Florida | 33321 | Recruiting |
| Research Site 04 | Tampa | Florida | 33607 | Recruiting |
| Research Site 05 | Tampa | Florida | 33617 | Recruiting |
| Research Site 02 | Ypsilanti | Michigan | 48197 | Recruiting |
| Research Site 11 | Dayton | Ohio | 45424 | Recruiting |
| Research Site 07 | Sugar Land | Texas | 77479 | Recruiting |
| Research Site 08 | Williamsburg | Virginia | 23188 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07359846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07359846 live on ClinicalTrials.gov.